View in EDS

BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?

Saved in:
Bibliographic Details
Title: BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?
Authors: Gallina FT; Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; Tumor Immunology and Immunotherapy Unit, IRCCS 'Regina Elena' National Cancer Institute, Rome, Italy. Electronic address: filippo.gallina@ifo.it., Cecere FL; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bergomi S; Division of Nuclear Medicine, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Buglioni S; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Visca P; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Landi L; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Cappuzzo F; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 May; Vol. 203, pp. 108514. Date of Electronic Publication: 2025 Apr 03.
Publication Type: Letter
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40187076
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gallina+FT%22">Gallina FT</searchLink>; Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; Tumor Immunology and Immunotherapy Unit, IRCCS 'Regina Elena' National Cancer Institute, Rome, Italy. Electronic address: filippo.gallina@ifo.it.<br /><searchLink fieldCode="AU" term="%22Cecere+FL%22">Cecere FL</searchLink>; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Bergomi+S%22">Bergomi S</searchLink>; Division of Nuclear Medicine, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Buglioni+S%22">Buglioni S</searchLink>; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Visca+P%22">Visca P</searchLink>; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Landi+L%22">Landi L</searchLink>; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Cappuzzo+F%22">Cappuzzo F</searchLink>; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228800805%22">Lung cancer (Amsterdam, Netherlands)</searchLink> [Lung Cancer] 2025 May; Vol. 203, pp. 108514. <i>Date of Electronic Publication: </i>2025 Apr 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8800805 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-8332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201695002%22">01695002 </searchLink><i>NLM ISO Abbreviation: </i>Lung Cancer <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40187076
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2025.108514
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108514
    Titles:
      – TitleFull: BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gallina FT
      – PersonEntity:
          Name:
            NameFull: Cecere FL
      – PersonEntity:
          Name:
            NameFull: Bergomi S
      – PersonEntity:
          Name:
            NameFull: Buglioni S
      – PersonEntity:
          Name:
            NameFull: Visca P
      – PersonEntity:
          Name:
            NameFull: Landi L
      – PersonEntity:
          Name:
            NameFull: Cappuzzo F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1872-8332
          Numbering:
            – Type: volume
              Value: 203
          Titles:
            – TitleFull: Lung cancer (Amsterdam, Netherlands)
              Type: main
ResultId 1